Featured

Immunotherapy and PLGG

April 4th, 2017|

Immunotherapy, including vaccines, is a promising area of research in cancer and as such was the subject of a pilot trial for a vaccine therapy funded by AKBTC. Dr. […]

Massachusetts General Hospital (MGH) Study Informs for Medulloblastoma patients

February 27th, 2017|

Massachusetts General Hospital (MGH) researchers have identified a mechanism that controls the expression of genes regulating the growth of the most aggressive form of medulloblastoma. In their report published […]

Pediatric Low Grade Gliomas: Implications of the Biologic Era

February 16th, 2017|

International Panel of Pediatric Brain Cancer Experts find Consensus on how to best integrate the growing body of molecular genetic information into tumor classifications and, more importantly, for future […]

Two new trials for pediatric brain cancer open at UTHealth/Children’s Memorial Hermann

February 6th, 2017|

Pediatric neurosurgeon Dr. David Sandberg of McGovern Medical School at UTHealth has pioneered administering chemotherapy in the fourth ventricle of the brain for pediatric brain cancers.   The pilot trials, […]

Publications GALORE in 2016 for DFCI Researchers

February 1st, 2017|

With the support of the PLGA fund-raising community, DFCI researchers had an explosive year in 2016 with discoveries in pediatric brain cancer research which impact a wide array of […]

Key Finding Identifies Most Promising Drug for Targeted Clinical Trial

January 24th, 2017|

As reported in Neuro-Oncology Magazine (January 12th, 2017), with leadership from the Dana Farber Cancer Institute’s Dr. Charles Stiles and up and coming researcher, Dr. Sarah Buhrlage, ground-breaking science […]

Precision Medicine Impacts Pediatric Brain Cancer Treatment

January 19th, 2017|

Precision medicine—in which diagnosis and treatments are keyed to the genetic susceptibilities of individual cancers—has advanced to the point where it can now impact the care of a majority […]

Brain Cancer Now the Leading Childhood Cancer Killer

September 21st, 2016|

According to newly released data by the U.S. Centers for Disease Control and Prevention (CDC), brain cancer is now the deadliest childhood cancer. For the first time, brain cancer […]

AKBTC Joins Solving Kids’ Cancer and the Ty Louis Campbell Foundation to Fund Phase 1 Clinical Trial

August 10th, 2016|

When 3 like-minded childhood cancer charities partner together, anything is possible! In the most recent collaboration, three New York based pediatric cancer charities, A Kids’ Brain Tumor Cure, The […]

Phase 1/II Study of MEK162 for Children with Ras/Raf Pathway Activated Tumors

August 10th, 2016|

With the discovery of new targets, the pipeline for PLGA clinical trials is ramping up to be more productive than ever before.  The newest PLGA clinical trial, entitled Phase […]